NCT04191447

Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma

Multicenter, Randomized, Double-blind, Double-dummy, National, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma .

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 134 (estimated)
• Sponsor: EMS · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of Flamboyant 200/12 association in adults with asthma.

Conditions

• Asthma

Interventions

Type	Name	Description
DRUG	Flamboyant 200/12	Flamboyant 200/12 capsule
DRUG	Budesonide / Formoterol 400/12	Budesonide / Formoterol 400/12 capsule
OTHER	Flamboyant 200/12 Placebo	Flamboyant 200/12 Placebo capsule
OTHER	Budesonide / Formoterol 400/12 Placebo	Budesonide / Formoterol 400/12 Placebo capsule

Timeline

• Start date: 2022-07-22
• Primary completion: 2023-07-01
• Completion: 2023-10-01
• First posted: 2019-12-09
• Last updated: 2022-07-27

Locations

1 site across 1 country: Brazil